In an interview in the journal Neuron, Stanford's Rob Malenka holds forth on a wide range of subjects stretching from reflections on his own career trajectory to his approach to boosting those of his trainees to the future of neuroscience itself.
Stanford scientists have figured out a way to convert common brewer’s yeast into an efficient factory for making a non-narcotic cough medicine that occurs naturally only in opium poppies.
Rheumatoid arthritis and coronary artery disease share a common culprit: an important type of immune cell, called a macrophage, that has gone haywire. Stanford investigators have zeroed in on a molecular defect in macrophages' metabolic process that drives both disorders.
The human brain, and how it works, is one of the great mysteries of science. If only you could grow a brain in a bottle, you could learn a lot about what can go wrong – or for that matter, what goes right – in early brain development. So that's why Sergiu Pasca did.
Researchers have identified an immune cell type with an apparently critical role in multiple sclerosis, and a way to block its entry into the brain.
A promising anti-cancer therapy works great at first, but then loses its punch. A clever workaround may provide high-octane efficacy, without side effects.
Many infectious diseases are marked by cyclical ups and downs. Stanford's David Schneider takes a creative approach to making sense of them.
New research suggests that targeting mitochondria could be a way to treat Parkinson's disease.
New Stanford Medicine research shows that a type of nerve cell called mossy cells play a key role in seizures in temporal lobe epilepsy.
A new study suggests that a blood test following exercise may be a good way to differentiate between people who have ME/CFS and people who don't.
A new study led by the late Ben Barres suggests that rogue astrocytes may be involved in memory loss in otherwise healthy older brains.
The study's finding is likely to translate into an increase in the number of acute-stroke patients receiving thrombectomies -- and likely save lives.
Stanford neuroscientist Ben Barres devoted his career to studying glial cells, which play a significant, but previously undervalued, role in the brain.
Just imagine if you could predict and prevent a burst of binge eating or alcohol intake, a heroin injection, a sudden bout of uncontrolled rage or …
It's not every day that early-stage research at Stanford's School of Medicine generates its own New Yorker cartoon. But a few years ago, news of a …
A study in Cell from the lab of Stanford psychiatrist, neuroscientist and bioengineer Karl Deisseroth, MD, PhD, demonstrates a new technology's power — it helped …